First-in-Human Study With GNbAC1 in Healthy Volunteers

NCT01699555 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: GNbAC1
BIOLOGICAL: GNbAC1 placebo

Sponsor

GeNeuro Innovation SAS